CINECA IRIS Institutional Research Information System

REIMONDO, Giuseppe Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.074
EU - Europa 4.547
AS - Asia 2.182
SA - Sud America 320
AF - Africa 101
OC - Oceania 83
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.861
CN - Cina 1.046
IT - Italia 1.039
DE - Germania 524
SE - Svezia 469
IE - Irlanda 447
UA - Ucraina 341
FR - Francia 313
GB - Regno Unito 231
FI - Finlandia 229
JP - Giappone 223
KR - Corea 210
PL - Polonia 191
TR - Turchia 152
VN - Vietnam 147
BR - Brasile 139
ES - Italia 135
CA - Canada 132
AT - Austria 121
IN - India 88
AU - Australia 79
RU - Federazione Russa 70
AR - Argentina 66
BE - Belgio 66
MX - Messico 66
NL - Olanda 56
GR - Grecia 53
HK - Hong Kong 46
HU - Ungheria 44
CO - Colombia 40
RO - Romania 36
SG - Singapore 36
CH - Svizzera 34
CL - Cile 34
IR - Iran 33
PT - Portogallo 32
TW - Taiwan 31
DK - Danimarca 29
RS - Serbia 29
DZ - Algeria 27
SN - Senegal 23
IL - Israele 22
TH - Thailandia 21
IQ - Iraq 19
ZA - Sudafrica 18
PH - Filippine 17
MY - Malesia 16
PE - Perù 16
ID - Indonesia 15
TN - Tunisia 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
SA - Arabia Saudita 11
SI - Slovenia 10
VE - Venezuela 9
EG - Egitto 8
PK - Pakistan 8
EU - Europa 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BA - Bosnia-Erzegovina 6
HR - Croazia 6
NO - Norvegia 6
SY - Repubblica araba siriana 5
UY - Uruguay 5
BH - Bahrain 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BG - Bulgaria 3
MA - Marocco 3
MU - Mauritius 3
NI - Nicaragua 3
TZ - Tanzania 3
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
PA - Panama 2
QA - Qatar 2
SM - San Marino 2
AP - ???statistics.table.value.countryCode.AP??? 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MM - Myanmar 1
MT - Malta 1
Totale 13.313
Salva come PNG Salva come JPEG
Città #
Chandler 800
Beijing 662
Dublin 437
Fairfield 378
Houston 342
Ashburn 283
Ann Arbor 229
Redwood City 203
Jacksonville 200
Wilmington 187
Torino 180
Woodbridge 179
Nyköping 162
Seattle 158
Medford 141
Cambridge 137
Princeton 126
Villeurbanne 115
Warsaw 114
Dearborn 113
Vienna 108
Dong Ket 96
Pisa 87
Milan 72
Turin 63
Rochester 59
Guangzhou 52
Rome 48
Boston 46
New York 45
Shanghai 45
Tokyo 44
Toronto 43
Istanbul 41
Fremont 38
Los Angeles 38
Buenos Aires 31
Ankara 30
Boardman 30
Würzburg 30
San Diego 29
Seoul 28
Hangzhou 27
Chicago 26
Brussels 25
Helsinki 25
Paris 25
Budapest 24
Moscow 24
Singapore 23
Taipei 23
Santiago 22
Bogotá 21
Hefei 21
Okazaki 21
Düsseldorf 20
London 20
Norwalk 19
Lachine 18
Munich 18
Seongnam 18
Athens 17
Nanjing 17
Phoenix 17
Madrid 16
Tehran 16
Lima 15
Osaka 15
Padova 15
São Paulo 15
Washington 15
Mountain View 14
Sydney 14
Zurich 14
Belgrade 13
Falls Church 13
Florence 13
Lappeenranta 13
Silver Spring 13
Trieste 13
Chengdu 12
San Jose 12
Brisbane 11
Fukuoka 11
Lund 11
Ottawa 11
Berlin 10
Gliwice 10
Jinan 10
Leiden 10
Nürnberg 10
Piemonte 10
Portland 10
Szekszárd 10
Verona 10
Xian 10
Zhengzhou 10
Barcelona 9
Birmingham 9
Central District 9
Totale 7.152
Salva come PNG Salva come JPEG
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 968
Autonomous hypercortisolism: definition and clinical implications 573
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. 459
AME position statement on adrenal incidentaloma. 405
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas 351
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 337
Thyroid and colorectal cancer screening in acromegaly patients: Should it be different from that in the general population? 288
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. 276
Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas 267
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 256
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 240
Surgical remission of Cushing's syndrome reduces cardiovascular risk. 235
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 230
Adjuvant mitotane treatment for adrenocortical carcinoma 230
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 224
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 215
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 211
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 185
Predictors of morbidity and mortality in acromegaly: an Italian survey. 173
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment. 164
Acromegaly is associated with increased cancer risk: a survey in Italy 158
Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis. 154
Comparison of Reverse Triage with National Early Warning Score, Sequential Organ Failure Assessment and Charlson Comorbidity Index to classify medical inpatients of an Italian II level hospital according to their resource's need. 153
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 148
Analysis of BclI, N363S and ER22/23EK polymorphism of the glucocorticoid receptor gene in a large series of patients with adrenal incidentaloma 143
Laboratory differentiation of Cushing's syndrome 140
Inpatient disposition in overcrowded hospitals: is it safe and effective to use reverse triage and readmission screening tools for appropriate discharge? An observational prospective study of an Italian II level hospital 134
Adrenal incidentaloma, a five year experience. 133
[Subclinical Cushing's syndrome in adrenal incidentalomas] 132
Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood 130
May an adrenal incidentaloma change its nature? 130
Insights on the natural history of adrenal incidentalomas 122
Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas 117
Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis? 113
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 107
Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study 107
Adrenocortical Carcinoma with Hypercortisolism. 106
Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. 105
Evaluation of cardiovascular risk factors in patients with incidentally discovered adrenal adenoma during a follow-up longer than five years 102
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 101
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 100
Acute Primary Adrenal Insufficiency after Hip Replacement in a Patient with Acute Intermittent Porphyria. 99
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 99
Cyclic Cushing's syndrome due to ectopic ACTH secretion by an adrenal pheochromocytoma. 98
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 97
Subclinical Cushing's syndrome 95
A prospective study on adjuvant mitotane 95
Sindrome di Cushing: l’esperienza dell’Ospedale San Luigi di Orbassano 92
Misdiagnosis of Cushing's syndrome in a patient receiving rifampicin therapy for tuberculosis. 88
Epidemiology of acromegaly in Italy 87
Desmopressin test in mild Cushing syndrome. 84
Adrenal pseudocyst mimicking cancer: a case report 84
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 84
Sindrome di cushing: esperienza dell'ospedale San Luigi di Orbassano in una serie consecutiva di 117 pazienti 83
Adrenal incidentaloma: a new cause of the metabolic syndrome? 82
Early introduction of simulation in the medical curriculum: the MedInTo perspective 80
Evaluation of Cardiovascular Risk Factors in Patients with Incidentally Discovered Adrenal Adenoma during a Follow-Up Longer Than Five Years. 80
Cardiovascular risk factors in patients with Cushing’s syndrome: data from a long term follow up after treatment 79
Circadian profile of serum melatonin in patients with Cushing's syndrome or acromegaly. 76
Autocrine down-regulation of glucocorticoid receptors by interleukin-11 in human osteoblast-like cell lines. 75
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 74
Is Follow-up of Adrenal Incidentalomas Always Mandatory? 72
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 71
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome 70
Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System 70
L'esperienza dell'ospedale san Luigi nel trattamento con mitotane adiuvante in pazienti operati radicalmente per carcinoma corticosurrenalico. 69
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome 68
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. 67
PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA. 67
Comparison of 1-mg versus 8-mg dexamethasone suppression test (DST) in patients with clinically inapparent adrenal adenoma 65
Demographic Data, Co-Morbidities, Malignancies and Mortality from the First Large-Scale Italian Study on Acromegaly. 65
Hyperhomocysteinemia in patients with Cushing's syndrome 65
Emerging drugs for adrenocortical carcinoma 62
Management of adrenal incidentalomas 61
Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome 61
Secondary hypoadrenalism 61
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 61
Midnight salivary cortisol for diagnosis of subclinical Cushing’s syndrome in patients with clinically inapparent adrenocortical adenoma. 60
Sindrome di Cushing: l'esperienza dell'ospedale San Luigi in una serie consecutiva di 117 pazienti 59
The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. 55
Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy 55
Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy 55
Long-term follow-up in adrenal incidentalomas: an Italian Multicentre Study 54
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study 54
Rapporto tra acromegalia e neoplasia: fantasia o realtà? 53
Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus 51
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 51
Ectopic ACTH syndrome: molecular bases and clinical heterogeneity. 50
Prolonged adrenal insufficiency after the discontinuation of mitotane therapy 49
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 48
The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome 47
May an altered hypothalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism? 47
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies 47
Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. 46
Risk of cardiovascular events in adrenal incidentalomas: an Italian long-term follow-up study 46
The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. 45
Reversibility of Acute Adrenal Insufficiency after hip Replacement: A Case Series 45
Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma 42
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series 42
Sindrome di Cushing: l’esperienza dell’Ospedale San Luigi in una serie consecutiva di 117 pazienti 42
Totale 12.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.233
article - articoli 0
book - libri 0
conference - conferenze 5.006
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019383 0 0 0 0 0 0 0 0 0 0 245 138
2019/20201.925 105 96 106 195 124 247 230 205 237 150 125 105
2020/20211.822 137 91 154 94 139 89 173 148 149 199 144 305
2021/20222.274 133 111 131 209 188 115 174 143 120 175 389 386
2022/20232.828 269 236 108 237 243 565 187 204 334 120 187 138
2023/20241.724 220 249 125 162 179 198 195 180 50 137 29 0
Totale 13.784